Theranostic and Combined Approaches Exploiting Multifunctional Gold Nanoclusters in Tumoral Ecosystems: A Paradigm

Shatrudhan Prajapati1, Shikha Yadav1, Javed Khan1

  • 1Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University, Greater Noida, Uttar Pradesh, India.

PubMed

Insights

Gold nanoclusters (AuNCs) show promise for advanced cancer diagnostics and therapies. These nanomaterials offer unique properties for imaging, drug delivery, and treatment, potentially improving outcomes for malignant tumors.

Area of Science:

  • Nanotechnology
  • Materials Science
  • Biomedical Engineering

Background:

  • Malignant tumors present a significant global health challenge.
  • Current diagnostic and treatment modalities for tumors are often insufficient.
  • Gold nanoclusters (AuNCs) are emerging nanomaterials with unique physicochemical properties.

Purpose of the Study:

  • To explore the potential of gold nanoclusters (AuNCs) in cancer theranostics and combination therapies.
  • To review the applications of AuNCs in diagnostics, drug delivery, and therapeutic treatments for tumors.
  • To highlight the advantages and limitations of AuNCs in pharmaceutical applications.

Main Methods:

  • Review of existing literature on gold nanoclusters (AuNCs) for cancer theranostics.
  • Discussion of AuNCs' properties, including fluorescence, photothermal effects, and biocompatibility.
  • Analysis of AuNC-based nanosystems for tumor targeting and therapeutic delivery.

Main Results:

  • AuNCs demonstrate significant potential as imaging agents, drug transporters, and therapeutic agents.
  • AuNCs can be utilized for light-activated and radiation-based cancer therapies.
  • Various methods exist for attaching anticancer drugs to AuNCs for targeted delivery.

Conclusions:

  • AuNCs offer a promising platform for advancing cancer diagnostics and combination therapies.
  • Further research into AuNCs could lead to novel pharmaceutical applications and improved cancer treatment strategies.
  • The development of AuNC-based devices, utilizing dynamic or passive tumor targeting, expands diagnostic capabilities in cancer therapy.

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K